Read + Share
Martin N, Wechsler ME, Brightling CE. Reply to: Response and remission in asthma with tezepelumab: overlapping concepts
informing on type-2 inflammatory-dependent treatment effects. Eur Respir J 2025;65:2402434.
PMID: 39947687
|
 |
|
Martin N, Wechsler ME, Brightling CE. Reply to: Response and remission in asthma with tezepelumab: overlapping concepts
informing on type-2 inflammatory-dependent treatment effects. Eur Respir J 2025;65:2402434.
PMID: 39947687
|
|
|
|